{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:21:44Z","timestamp":1754558504921,"version":"3.27.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Higher Education Association of Jiangsu Province","award":["SGY21A008"],"award-info":[{"award-number":["SGY21A008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-64216-z","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T16:02:45Z","timestamp":1725984165000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy"],"prefix":"10.1038","volume":"14","author":[{"given":"Yun","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sainan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"64216_CR1","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle, K. R. et al. Diabetic kidney disease: A report from an ADA consensus conference. Diabetes Care 37, 2864\u20132883. https:\/\/doi.org\/10.2337\/dc14-1296 (2014).","journal-title":"Diabetes Care"},{"key":"64216_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.19538\/j.nk2017030108","volume":"37","author":"G Tong","year":"2017","unstructured":"Tong, G. & Zhu, D. Interpretation of clinical practice guidelines and expert consensuses for the evaluation and management of diabetic kidney disease at home and abroad. Chin. J. Pract. Internal Med. 37, 211\u2013216. https:\/\/doi.org\/10.19538\/j.nk2017030108 (2017).","journal-title":"Chin. J. Pract. Internal Med."},{"key":"64216_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.16386\/j.cjpccd.issn.1004-6194.2011.05.036","volume":"19","author":"S Wang","year":"2011","unstructured":"Wang, S. et al. Analysis of the influence of metabolic syndrome on diabetic nephropathy in type 2 diabetes. Chin. J. Prev. Control Chron. Dis. 19, 509\u2013511. https:\/\/doi.org\/10.16386\/j.cjpccd.issn.1004-6194.2011.05.036 (2011).","journal-title":"Chin. J. Prev. Control Chron. Dis."},{"key":"64216_CR4","first-page":"183","volume":"1","author":"L Fan","year":"1992","unstructured":"Fan, L. & Zheng, S. Research progress of early diagnosis and treatment of diabetic nephropathy. Guizhou Med. J. 1, 183\u2013185 (1992).","journal-title":"Guizhou Med. J."},{"key":"64216_CR5","first-page":"1665","volume":"36","author":"L Zhao","year":"2016","unstructured":"Zhao, L. & Ma, K. Effect of continuous quality improvement model combined with psychological nursing in the application of low blood sugar management and negative emotion in patients with diabetic nephropathy. J. Clin. Pathol. Res. 36, 1665\u20131669 (2016).","journal-title":"J. Clin. Pathol. Res."},{"key":"64216_CR6","volume-title":"The Economic Burden and Some Related Factors of type 2 Diabetes Mellitus (T2DM) and its Complications in Urban China","author":"L Tang","year":"2004","unstructured":"Tang, L. The Economic Burden and Some Related Factors of type 2 Diabetes Mellitus (T2DM) and its Complications in Urban China (Fudang University, Fudang, 2004)."},{"key":"64216_CR7","first-page":"663","volume":"32","author":"L Liu","year":"2011","unstructured":"Liu, L., Hu, K., Jin, S. & Liu, J. Hospitalization cost analysis of patients with different type II diabetes mellitus subtypes. Acad. J. Chin. PLA Med. Sch. 32, 663\u2013666 (2011).","journal-title":"Acad. J. Chin. PLA Med. Sch."},{"key":"64216_CR8","first-page":"32","volume":"32","author":"J Zhu","year":"2013","unstructured":"Zhu, J., Fan, W., Huang, Y. & Chen, W. Economic burden of type 2 diabetes mellitus with nephropathy complications in China. Chin. Health Econ. 32, 32\u201334 (2013).","journal-title":"Chin. Health Econ."},{"key":"64216_CR9","first-page":"421","volume":"15","author":"X Yang","year":"2015","unstructured":"Yang, X. & Ren, Y. Research progress on the pharmacologic actions of safflower yellow. J. Trop. Med. 15, 421\u2013424 (2015).","journal-title":"J. Trop. Med."},{"key":"64216_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA: J. Am. Med. Assoc. 283, 1 (2000).","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"64216_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jval.2013.02.010","volume":"16","author":"D Husereau","year":"2013","unstructured":"Husereau, D. et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)\u2014Explanation and elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 16, 1 (2013).","journal-title":"Value Health"},{"key":"64216_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.16305\/j.1007-1334.2007.07.003","volume":"1","author":"N Yang","year":"2007","unstructured":"Yang, N. & Liu, X. Criteria of diagnosis, syndrome differentiation and efficacy evaluation on diabetic kidney disease (Trial). Shanghai J. Tradit. Chin. Med. 1, 7\u20138. https:\/\/doi.org\/10.16305\/j.1007-1334.2007.07.003 (2007).","journal-title":"Shanghai J. Tradit. Chin. Med."},{"key":"64216_CR13","unstructured":"Higgins, J. & Green, S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration. (2013)."},{"key":"64216_CR14","first-page":"7","volume":"36","author":"F Qi","year":"2015","unstructured":"Qi, F. et al. Common costs and their estimation methods in pharmacoeconomics. Shanghai Med. Pharm. J. 36, 7\u20139 (2015).","journal-title":"Shanghai Med. Pharm. J."},{"key":"64216_CR15","first-page":"53","volume":"24","author":"F Yu","year":"2012","unstructured":"Yu, F. & Yan, S. Cost-effectiveness analyses of 3 kinds of traditional Chinese medicinal injections in the treatment of coronary heart disease-induced angina pectoris caused. Tianjin Pharm. 24, 53\u201354 (2012).","journal-title":"Tianjin Pharm."},{"key":"64216_CR16","unstructured":"Drug price inquiry website. https:\/\/www.315jiage.cn."},{"key":"64216_CR17","volume-title":"The Study on the Burden of Diabetes in China","author":"Z Zhang","year":"2007","unstructured":"Zhang, Z. The Study on the Burden of Diabetes in China (Fudang University Press, Fudang, 2007)."},{"key":"64216_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.13286\/j.cnki.chinhosppharmacyj.2019.05.15","volume":"39","author":"X Guan","year":"2019","unstructured":"Guan, X., Li, H., Shao, R., He, Y. & Ma, A. A systematic review and economic evaluation of one-week esomeprazole-based triple therapy versus omeprazole-based triple therapy for patients with peptic ulcer. Chin. J. Hosp. Pharm. 39, 502\u2013507. https:\/\/doi.org\/10.13286\/j.cnki.chinhosppharmacyj.2019.05.15 (2019).","journal-title":"Chin. J. Hosp. Pharm."},{"key":"64216_CR19","first-page":"698","volume":"13","author":"X Bai","year":"2012","unstructured":"Bai, X., Li, X., Song, J., Zhang, X. & Li, H. Soflor yellow on hs-CRP and IL-8 in patients with early diabetic nephropathy. Chin. J. Integrat. Tradit. Western Nephrol. 13, 698\u2013700 (2012).","journal-title":"Chin. J. Integrat. Tradit. Western Nephrol."},{"key":"64216_CR20","first-page":"1664","volume":"39","author":"X Bao","year":"2017","unstructured":"Bao, X. et al. Effects of safflower yellow combined with metformin on NF-\u03baB signaling pathway of patients with early diabetic nephropathy. Hebei Med. J. 39, 1664\u20131666 (2017).","journal-title":"Hebei Med. J."},{"key":"64216_CR21","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.13241\/j.cnki.pmb.2015.22.034","volume":"15","author":"Y Gao","year":"2015","unstructured":"Gao, Y. et al. Effect of soffor yellow combined with benazepril on the renal function of patients with early diabetic nephropathy. Progress Mod. Biomed. 15, 4333\u20134336. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2015.22.034 (2015).","journal-title":"Progress Mod. Biomed."},{"key":"64216_CR22","first-page":"27","volume":"55","author":"Z Li","year":"2012","unstructured":"Li, Z. & Wang, W. Efficacy of safflower yellow combined with losartan potassium in the treatment of early diabetic nephropathy. People\u2019s Milit. Surg. 55, 27\u201328 (2012).","journal-title":"People's Milit. Surg."},{"key":"64216_CR23","first-page":"805","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu, J., Lu, L., Hu, F. & Yuan, H. Effects of safflower yellow on insulin resistance and hypercoagulability in patients with early type 2 diabetic nephropathy. Chin. J. Difficult Complicat. Cases 18, 805\u2013808 (2019).","journal-title":"Chin. J. Difficult Complicat. Cases"},{"key":"64216_CR24","first-page":"4140","volume":"28","author":"X Fang","year":"2017","unstructured":"Fang, X., Li, X. & Liu, X. Clinical observation of safflower yellow pigment in the treatment of elderly patients with diabetic nephropathy complicated with acute myocardial infarction. China Pharm. 28, 4140\u20134143 (2017).","journal-title":"China Pharm."},{"key":"64216_CR25","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.13241\/j.cnki.pmb.2013.30.027","volume":"13","author":"T Qiu","year":"2013","unstructured":"Qiu, T., Wang, X., Yuan, J., Wang, G. & Wang, M. Observation on the clinical effect of safflower yellow pigment injection in the adjuvant treatment of early diabetic nephropathy. Progress Mod. Biomed. 13, 5975\u20135977. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2013.30.027 (2013).","journal-title":"Progress Mod. Biomed."},{"key":"64216_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.14009\/j.issn.1672-2124.2017.10.028","volume":"17","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Liu, Y. & Ran, H. Observation on efficacy of carthamin yellow combined with metformin in treatment of early diabetic nephropathy. Eval. Anal. Drug-Use Hosp. China 17, 1370\u20131371. https:\/\/doi.org\/10.14009\/j.issn.1672-2124.2017.10.028 (2017).","journal-title":"Eval. Anal. Drug-Use Hosp. China"},{"key":"64216_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.16040\/j.cnki.cn15-1101.2017.16.054","volume":"36","author":"L Duan","year":"2017","unstructured":"Duan, L., Li, J. & Jiang, X. Analysis of clinical efficacy of safflower yellow powder injection combined with alprostadil on diabetic nephropathy. Nei Mongol J. Tradit. Chin. Med. 36, 53\u201354. https:\/\/doi.org\/10.16040\/j.cnki.cn15-1101.2017.16.054 (2017).","journal-title":"Nei Mongol J. Tradit. Chin. Med."},{"key":"64216_CR28","first-page":"137","volume":"12","author":"Y Feng","year":"2016","unstructured":"Feng, Y. Effect of safflower yellow injection combined with Shenmai Injection on expression of urinary protein in early diabetic nephropathy. Asia-Pac. Tradit. Med. 12, 137\u2013138 (2016).","journal-title":"Asia-Pac. Tradit. Med."},{"key":"64216_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.15921\/j.cnki.cyxb.2016.03.006","volume":"33","author":"Y Xiao","year":"2016","unstructured":"Xiao, Y. & Gu, Y. Influences of sofflor yellow on inflammatory reaction and proteinuria of patients with diabetic nephropathy. J. Chengde Med. Coll. 33, 194\u2013196. https:\/\/doi.org\/10.15921\/j.cnki.cyxb.2016.03.006 (2016).","journal-title":"J. Chengde Med. Coll."},{"key":"64216_CR30","first-page":"986","volume":"39","author":"Y Gao","year":"2015","unstructured":"Gao, Y., Yuan, L., Zhang, L. & Liu, N. Analysis of 44 cases of safflower yellow combined with telmisartan in the treatment of early diabetic nephropathy. Guizhou Med. J. 39, 986\u2013988 (2015).","journal-title":"Guizhou Med. J."},{"key":"64216_CR31","first-page":"258","volume":"20","author":"H Yu","year":"2014","unstructured":"Yu, H. et al. Soffor yellow injection therapy in patients with unstable angina and diabeticnephropathy. Chin. J. Thrombos. Hemostas. 20, 258\u2013259 (2014).","journal-title":"Chin. J. Thrombos. Hemostas."},{"key":"64216_CR32","first-page":"134","volume":"11","author":"Z Fang","year":"2015","unstructured":"Fang, Z. Clinical study on valsartan combined with safflower yellow in the treatment of diabetic nephropathy proteinuria. Asia-Pac. Tradit. Med. 11, 134\u2013135 (2015).","journal-title":"Asia-Pac. Tradit. Med."},{"key":"64216_CR33","first-page":"99","volume":"35","author":"S Wu","year":"2019","unstructured":"Wu, S., Zeng, B. & Lin, S. Clinical observation of safflower yellow injection in the treatment of diabetic renal failure. Chin. Commun. Doct. 35, 99 (2019).","journal-title":"Chin. Commun. Doct."},{"key":"64216_CR34","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.13192\/j.issn.1000-1719.2018.12.036","volume":"45","author":"R Xie","year":"2018","unstructured":"Xie, R. et al. Effect of sulodexide combined with carthamin yellow on renal function and blood lipid in DN patients. Liaon. J. Tradit. Chin. Med. 45, 2576\u20132578. https:\/\/doi.org\/10.13192\/j.issn.1000-1719.2018.12.036 (2018).","journal-title":"Liaon. J. Tradit. Chin. Med."},{"key":"64216_CR35","first-page":"32","volume":"11","author":"T Xu","year":"2014","unstructured":"Xu, T. & He, C. Efficacy of safflower yellow injection combined with pancreatic kininogenase in the treatment of early diabetic nephropathy. J. North Pharm. 11, 32\u201333 (2014).","journal-title":"J. North Pharm."},{"key":"64216_CR36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.13493\/j.issn.1672-7878.2015.06-065","volume":"12","author":"S Yan","year":"2015","unstructured":"Yan, S. & Liu, J. Clinical efficacy evaluation of safflower yellow injection combined with valsartan in the treatment of early diabetic nephropathy. Anti-infect. Pharm. 12, 963\u2013965. https:\/\/doi.org\/10.13493\/j.issn.1672-7878.2015.06-065 (2015).","journal-title":"Anti-infect. Pharm."},{"key":"64216_CR37","first-page":"147","volume":"9","author":"B Yang","year":"2011","unstructured":"Yang, B., Yang, L., Yang, X. & Chen, B. Clinical efficacy of\u00a0safflower yellow injection in the treatment of\u00a0diabetic nephropathy. Seek Med. Ask Med. 9, 147 (2011).","journal-title":"Seek Med. Ask Med."},{"key":"64216_CR38","doi-asserted-by":"publisher","first-page":"304","DOI":"10.16294\/j.cnki.1007-659x.2007.04.017","volume":"1","author":"X Yang","year":"2007","unstructured":"Yang, X. Clinical observation of safflower yellow sodium chloride injection in the treatment of early diabetic nephropathy. J. Shand. Univ. Tradit. Chin. Med. 1, 304\u2013305. https:\/\/doi.org\/10.16294\/j.cnki.1007-659x.2007.04.017 (2007).","journal-title":"J. Shand. Univ. Tradit. Chin. Med."},{"key":"64216_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1654\/j.cnki.53-1120\/r.2012.04.046","volume":"33","author":"X Yang","year":"2012","unstructured":"Yang, X. & Dai, Li. The explore of the protective effect of\u00a0safflower yellow injection combined with alpha-lipoic acid in treating the patients with type 2 diabetes and early signs of nephropathy. J. Tradit. Chin. Med. Mater. Med. 33, 23\u201324. https:\/\/doi.org\/10.1654\/j.cnki.53-1120\/r.2012.04.046 (2012).","journal-title":"J. Tradit. Chin. Med. Mater. Med."},{"key":"64216_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.16659\/j.cnki.1672-5654.2012.32.110","volume":"9","author":"S Jiao","year":"2012","unstructured":"Jiao, S. & Zhang, C. Clinical observation of acupoint Injection of safflower yellow injection in the treatment of early diabetic nephropathy. China Health Industry 9, 81. https:\/\/doi.org\/10.16659\/j.cnki.1672-5654.2012.32.110 (2012).","journal-title":"China Health Industry"},{"key":"64216_CR41","first-page":"51","volume":"22","author":"M Yin","year":"2018","unstructured":"Yin, M. Influence of carthamin yellow pigment injection on oxidative stress indexes and inflammatory factors of patients with early diabetic nephropathy. J. Clin. Med. Pract. 22, 51\u201354 (2018).","journal-title":"J. Clin. Med. Pract."},{"key":"64216_CR42","first-page":"259","volume":"42","author":"Y Guo","year":"2010","unstructured":"Guo, Y. & Jiao, J. Observation on efficacy of safflower yellow pigment lyophilized power in the treatment of diabetic nephropathy. Qingdao Med. J. 42, 259\u2013260 (2010).","journal-title":"Qingdao Med. J."},{"key":"64216_CR43","first-page":"502","volume":"19","author":"L Yang","year":"2010","unstructured":"Yang, L. & Yang, G. Clinical research on safflower yellow in treatment of early type 2 diabetic nephropathy. Proc. Clin. Med. 19, 502\u2013503 (2010).","journal-title":"Proc. Clin. Med."},{"key":"64216_CR44","first-page":"360","volume":"1","author":"D Guo","year":"2008","unstructured":"Guo, D., Wang, Y., Chen, Z., Bian, D. & Qi, H. Efficacy of treatment in 39 patients with diabetic nephropathy by safflor yellow and benazepril in combination. Chin. J. Integr. Tradit. West. Med. 1, 360\u2013363 (2008).","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"64216_CR45","first-page":"24","volume":"11","author":"X Zhang","year":"2010","unstructured":"Zhang, X. Clinical efficacy of safflower yellow injection combined with irbesartan in the treatment of diabetic nephropathy. Pract. Clin. Med. 11, 24\u201326 (2010).","journal-title":"Pract. Clin. Med."},{"key":"64216_CR46","first-page":"3431","volume":"26","author":"Z Shi","year":"2015","unstructured":"Shi, Z. The effect of valsartan combined with safflower yellow on UAER and hs-CRP in diabetic nephropathy. Mod. Diagnosis Treatment 26, 3431\u20133432 (2015).","journal-title":"Mod. Diagnosis Treatment"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64216-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T09:03:45Z","timestamp":1729155825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64216-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["64216"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-64216-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"12 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21140"}}